Genetics of drug response to immunosuppressive treatment and prospects for personalized therapy
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Molecular Medicine Today
- Vol. 6 (12) , 475-482
- https://doi.org/10.1016/s1357-4310(00)01822-0
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Azathioprine Associated T‐Cell Mutations in Insulin‐Dependent Diabetes MellitusScandinavian Journal of Immunology, 2000
- A human class II MHC–derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signalingJournal of Clinical Investigation, 2000
- Skin cancer in liver transplant recipientsLiver Transplantation, 2000
- Screening for azathioprine toxicity: A pharmacoeconomic analysis based on a target caseJournal of the American Academy of Dermatology, 2000
- The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseEuropean Journal Of Cancer, 2000
- Interactions of Calcineurin A, Calcineurin B, and Ca2+Biochemistry, 1999
- Lymphoma in Patients with Rheumatoid ArthritisDrug Safety, 1999
- Evaluation of the frequency of HLA determinants in patients with gingival overgrowth induced by cyclosporine‐AJournal of Clinical Periodontology, 1996
- Mutations That Perturb Cyclophilin A Ligand Binding Pocket Confer Cyclosporin A Resistance in SaccharomycescerevisiaeJournal of Biological Chemistry, 1995
- FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cellsEuropean Journal of Immunology, 1995